292865-36-2

Upstream product

• 22818-40-2 D-4-hydroxyphenylglycine 
• 37763-23-8 D-2-p-hydroxyphenylglycine methyl ester 
• 292865-33-9 N-[1-(3-bromo-4-methoxy-phenyl)-2-hydroxy-ethyl]-2,2-dimethyl-propionamide 
• 292865-34-0 N-[1-(3-bromo-4-methoxy-phenyl)-2-chloro-ethyl]-2,2-dimethyl-propionamide 
• 292865-32-8 (R)-(2,2-Dimethyl-propionylamino)-(4-hydroxy-phenyl)-acetic acid methyl ester 
• 292865-31-7 4-(3-bromo-4-methoxy-phenyl)-2-tert-butyl-4,5-dihydro-oxazole 
• 119098-80-5 4,5-dihydro-2-(2,3,5-trimethoxyphenyl)-4,4-dimethyloxazole 
• 292865-35-1 2-[5'-((R)-2-tert-Butyl-4,5-dihydro-oxazol-4-yl)-4,6,2'-trimethoxy-biphenyl-2-yl]-4,4-dimethyl-4,5-dihydro-oxazole 

Downstream Products

• 292865-37-3 2,2-Dimethyl-propionic acid (R)-2-benzyloxycarbonylamino-2-[2'-(4,4-dimethyl-4,5-dihydro-oxazol-2-yl)-6,4',6'-trimethoxy-biphenyl-3-yl]-ethyl ester 
• 292865-38-4 2,2-Dimethyl-propionic acid (R)-2-benzyloxycarbonylamino-2-(6'-formyl-6,2',4'-trimethoxy-biphenyl-3-yl)-ethyl ester 

Relevant academic research and scientific papers

Asymmetric synthesis of actinoidic acid derivatives

(equation presented) Synthesis of fully protected actinoidic acid derivative 3 and selectively protected biaryl bisamino acid 4, intermediates for vancomycin total synthesis, are reported.